Microvolt T-Wave Alternans for Arrhythmia Risk Stratification in Left Ventricular Dysfunction. Which Patients Benefit?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 2, 2007, Pages 174-175

  Klingenheben, Thomas ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; EDITORIAL; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RISK ASSESSMENT; SURVIVAL; T WAVE;

ARRHYTHMIA; DISEASE-FREE SURVIVAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; PROGNOSIS; RISK ASSESSMENT; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34347264859     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.05.002     Document Type: Editorial

References (17)

1. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
2. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
4. Klingenheben T., Zabel M., D'Agostino R.B., et al. Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356 (2000) 651-652
5. Hohnloser S.H., Klingenheben T., Bloomfield D.M., et al. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 41 (2003) 2220-2224
6. Bloomfield D.M., Bigger J.T., Steinman R.C., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
7. Hohnloser S.H., Ikeda T., Bloomfield D.M., et al. T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362 (2003) 125-126
8. Bloomfield D.M., Steinman R.C., Namerow P.B., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II conundrum. Circulation 110 (2004) 1885-1889
9. Chow T., Kereiakes D.J., Bartone C., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
10. Chow T., Kereiakes D.J., Bartone C., et al. Mirovolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 49 (2007) 50-58
11. Gehi A.K., Stein R.H., Metz L.D., et al. Microvolt T-wave alternans for the risk stratification of ventricular tachyarrhythmic events: a meta-analysis. J Am Coll Cardiol 46 (2005) 75-82
12. Cantillon D.J., Stein K.M., Markowitz S.M., et al. Predictive value of microvolt T-wave alternans in patients with left ventricular dysfunction. J Am Coll Cardiol 50 (2007) 166-173
13. Rashba E.J., Osman A.F., MacMurdy K., et al. Exercise is superior to pacing for T-wave alternans measurements in subjects with chronic coronary artery disease and left ventricular dysfunction. J Cardiovasc Electrophysiol 13 (2002) 845-850
14. Costantini O., Rosenbaum D.S., Hohnloser S.H., et al., ABCD Investigators. The Alternans Before Cardioverter Defibrillator (ABCD) trial: a noninvasive strategy for primary prevention of sudden cardiac death using T-wave alternans. (abstr). Circulation 114 (2006) 2426
15. MASTER-I: Microvolt T-Wave Alternans Testing for Risk Stratification of Post-MI Patients. Available at: http://clinicaltrials.gov/ct/show/NCT00305240. Accessed May 22, 2007.
16. REFINE: Risk Estimation Following Infarction Noninvasive Evaluation. Available at: http://clinicaltrials.gov/ct/show/NCT00399503?order=1. Accessed May 22, 2007.
17. Salerno-Uriarte J.A., Pedretti R.F., Tritto M., et al. The ALPHA study (T-Wave Alternans in Patients With Heart Failure): rationale, design, and endpoints. Ital Heart J 5 (2004) 587-592